Alges-X forte Liquid Caps 400 mg

Alges-X forte Liquid Caps 400 mg is a medicine authorised by Swissmedic under authorisation number 69537. The authorisation holder is axapharm ag. The medicinal product code is Synthetic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 15 November 2024 and the authorisation is limited until 14 November 2029. ATC code M01AE01 places the medicine in the group Anti-inflammatory and antirheumatic products.

Dispensing category D
Authorisation number 69537
ATC M01AE01
Synthetic medicines

Authorisation data
Authorisation number	69537
Name	Alges-X forte Liquid Caps 400 mg
Full name	Alges-X forte Liquid Caps 400 mg, Weichkapseln
Authorisation holder	axapharm ag
Medicinal product code	Synthetic medicines
Dispensing category	D · No prescription, with advice
ATC code	M01AE01
First authorisation	15 November 2024
Authorisation validity	14 November 2029

Strengths
No.	Name	Dispensing category	Authorisation date
1	Alges-X forte Liquid Caps 400 mg, Weichkapseln	D	15 November 2024

Scroll the table sideways

Pack sizes
Pack code	Quantity	Unit	ATC	IT code	Dispensing category
1	10	Kapsel(n)	M01AE01	07.10.1.	D

Scroll the table sideways

Medicines in the same ATC group

Afelor Liquid Caps 200 mgAuthorisation number 69402 · NOBEL Pharma Schweiz AG · ATC M01AE01D Afelor Lysinat 200 mgAuthorisation number 69416 · NOBEL Pharma Schweiz AG · ATC M01AE01D Alcacyl Ibu 400Authorisation number 70425 · Hänseler AG · ATC M01AE01D Alges-X LAuthorisation number 66943 · axapharm ag · ATC M01AE01D Alges-X forteAuthorisation number 58313 · axapharm ag · ATC M01AE01D Algifor Dolo JuniorAuthorisation number 58834 · Verfora SA · ATC M01AE01D Algifor Dolo JuniorAuthorisation number 65608 · Verfora SA · ATC M01AE01D Algifor Dolo forte 200 mg / 5 mlAuthorisation number 65916 · Verfora SA · ATC M01AE01D Algifor JuniorAuthorisation number 56046 · Verfora SA · ATC M01AE01B Algifor Liquid caps 400Authorisation number 65372 · Verfora SA · ATC M01AE01D Algifor-L 200Authorisation number 54997 · Verfora SA · ATC M01AE01D Algifor-L 200Authorisation number 55766 · Verfora SA · ATC M01AE01D

Other medicines from this authorisation holder

ASS Cardio axapharm 100 mgAuthorisation number 66360 · ATC B01AC06B Acido-XAuthorisation number 61354 · ATC A02BC02D Alfuzosin axapharmAuthorisation number 59415 · ATC G04CA01B Alges-X LAuthorisation number 66943 · ATC M01AE01D Alges-X forteAuthorisation number 58313 · ATC M01AE01D Allergo-XAuthorisation number 66261 · ATC R06AE09D Amlo axapharm 5 mgAuthorisation number 70018 · ATC C08CA01B Amlodipin axapharm 5 mgAuthorisation number 59421 · ATC C08CA01B

Frequently asked questions

Is Alges-X forte Liquid Caps 400 mg authorised in Switzerland?

Yes. Alges-X forte Liquid Caps 400 mg is authorised by Swissmedic under authorisation number 69537, data as of 01 September 2026. The authorisation is limited until 14 November 2029.

Which dispensing category does Alges-X forte Liquid Caps 400 mg have?

Alges-X forte Liquid Caps 400 mg is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.

Who is the authorisation holder of Alges-X forte Liquid Caps 400 mg?

The authorisation holder is axapharm ag. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.